These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38984118)

  • 1. A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial.
    Gioia N; Gerson J; Ryan R; Barbour K; Poteet J; Jennings B; Sharp M; Lowery R; Wilson J; Morde A; Rai D; Padigaru M; Periman LM
    Front Ophthalmol (Lausanne); 2024; 4():1362113. PubMed ID: 38984118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Multi-Ingredient Supplement Reduces Inflammation of the Eye and Improves Production and Quality of Tears in Humans.
    Radkar P; Lakshmanan PS; Mary JJ; Chaudhary S; Durairaj SK
    Ophthalmol Ther; 2021 Sep; 10(3):581-599. PubMed ID: 34129210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous serum eye drops for dry eye.
    Pan Q; Angelina A; Marrone M; Stark WJ; Akpek EK
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009327. PubMed ID: 28245347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain.
    Ozen S; Ozer MA; Akdemir MO
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1173-1177. PubMed ID: 28299439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease.
    ; Asbell PA; Maguire MG; Pistilli M; Ying GS; Szczotka-Flynn LB; Hardten DR; Lin MC; Shtein RM
    N Engl J Med; 2018 May; 378(18):1681-1690. PubMed ID: 29652551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease.
    Taylor M; Ousler G; Torkildsen G; Walshe C; Fyfe MCT; Rowley A; Webber S; Sheppard JD; Duggal A
    Clin Ophthalmol; 2019; 13():261-275. PubMed ID: 30858682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral antibiotics for chronic blepharitis.
    Onghanseng N; Ng SM; Halim MS; Nguyen QD
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013697. PubMed ID: 34107053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical corticosteroids for dry eye.
    Liu SH; Saldanha IJ; Abraham AG; Rittiphairoj T; Hauswirth S; Gregory D; Ifantides C; Li T
    Cochrane Database Syst Rev; 2022 Oct; 10(10):CD015070. PubMed ID: 36269562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease.
    Deinema LA; Vingrys AJ; Wong CY; Jackson DC; Chinnery HR; Downie LE
    Ophthalmology; 2017 Jan; 124(1):43-52. PubMed ID: 27817918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study.
    Wang TJ; Wang IJ; Ho JD; Chou HC; Lin SY; Huang MC
    Clin Ther; 2010 Jan; 32(1):44-52. PubMed ID: 20171410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-α inhibitor tanfanercept (HBM9036) improves signs and symptoms of dry eye in a phase 2 trial in the controlled adverse environment in China.
    Dong Y; Wang S; Cong L; Zhang T; Cheng J; Yang N; Qu X; Li D; Zhou X; Wang H; Lee M; Wang M; Chen S; Ousler GW; Chen X; Xie L
    Int Ophthalmol; 2022 Aug; 42(8):2459-2472. PubMed ID: 35192105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age Associations with Dry Eye Clinical Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study.
    Zhao M; Yu Y; Ying GS; Asbell PA; Bunya VY;
    Ophthalmol Sci; 2023 Jun; 3(2):100270. PubMed ID: 36846104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye.
    Khamar P; Nair AP; Shetty R; Vaidya T; Subramani M; Ponnalagu M; Dhamodaran K; D'souza S; Ghosh A; Pahuja N; Deshmukh R; Ahuja P; Sainani K; Nuijts RMMA; Das D; Ghosh A; Sethu S
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2532-2542. PubMed ID: 31195410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral vitamin D supplementation on dry eye disease patients with vitamin D deficiency.
    Najjaran M; Zarei-Ghanavati S; Arjmand Askari E; Eslampoor A; Ziaei M
    Clin Exp Optom; 2023 Apr; 106(3):257-262. PubMed ID: 35188874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.
    Downie LE; Ng SM; Lindsley KB; Akpek EK
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a Novel Omega-3 and Omega-6 Fatty Acid Supplement on Dry Eye Disease: A 3-month Randomized Controlled Trial.
    Ng A; Woods J; Jahn T; Jones LW; Sullivan Ritter J
    Optom Vis Sci; 2022 Jan; 99(1):67-75. PubMed ID: 34882608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
    Lievens C; Berdy G; Douglass D; Montaquila S; Lin H; Simmons P; Carlisle-Wilcox C; Vehige J; Haque S
    Cont Lens Anterior Eye; 2019 Aug; 42(4):443-449. PubMed ID: 30573298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Integrated Active Herbal Formulation Ameliorates Dry Eye Syndrome by Inhibiting Inflammation and Oxidative Stress and Enhancing Glycosylated Phosphoproteins in Rats.
    Muz OE; Orhan C; Erten F; Tuzcu M; Ozercan IH; Singh P; Morde A; Padigaru M; Rai D; Sahin K
    Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33036453
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.